Amy C. Doty

559 total citations
9 papers, 331 citations indexed

About

Amy C. Doty is a scholar working on Pharmaceutical Science, Molecular Biology and Biomaterials. According to data from OpenAlex, Amy C. Doty has authored 9 papers receiving a total of 331 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pharmaceutical Science, 4 papers in Molecular Biology and 3 papers in Biomaterials. Recurrent topics in Amy C. Doty's work include Advanced Drug Delivery Systems (4 papers), Nanoparticle-Based Drug Delivery (3 papers) and Drug Solubulity and Delivery Systems (3 papers). Amy C. Doty is often cited by papers focused on Advanced Drug Delivery Systems (4 papers), Nanoparticle-Based Drug Delivery (3 papers) and Drug Solubulity and Delivery Systems (3 papers). Amy C. Doty collaborates with scholars based in United States. Amy C. Doty's co-authors include Steven P. Schwendeman, Stephanie Choi, Keiji Hirota, Yan Wang, Rose Ackermann, Karl Olsen, Wen Qu, Bryce Chiang, Mark R. Prausnitz and Steven P. Schwendeman and has published in prestigious journals such as Biomaterials, Journal of Controlled Release and Journal of Pharmaceutical Sciences.

In The Last Decade

Amy C. Doty

8 papers receiving 326 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Amy C. Doty United States	7	179	71	68	56	46	9	331
Zeinab Fathalla Egypt	9	271 1.5×	74 1.0×	82 1.2×	38 0.7×	126 2.7×	21	472
Hannah McMillan United Kingdom	4	262 1.5×	71 1.0×	58 0.9×	48 0.9×	145 3.2×	4	376
Divyesh H. Shastri India	9	179 1.0×	53 0.7×	55 0.8×	20 0.4×	72 1.6×	20	290
Rongcai Liang China	13	187 1.0×	89 1.3×	109 1.6×	18 0.3×	21 0.5×	20	353
Heba F. Mansour Egypt	14	238 1.3×	47 0.7×	70 1.0×	16 0.3×	55 1.2×	20	426
Abdelhalim I. Elassasy Egypt	7	265 1.5×	41 0.6×	81 1.2×	38 0.7×	82 1.8×	8	397
Marina Juretić Croatia	9	212 1.2×	64 0.9×	40 0.6×	28 0.5×	124 2.7×	10	367
Laurent Marchal‐Heussler France	9	239 1.3×	113 1.6×	76 1.1×	29 0.5×	110 2.4×	15	392
Doaa H. Hassan Egypt	10	155 0.9×	57 0.8×	63 0.9×	25 0.4×	40 0.9×	14	314
Araz Sabzevari Iran	10	239 1.3×	135 1.9×	96 1.4×	110 2.0×	67 1.5×	14	517

Countries citing papers authored by Amy C. Doty

Since Specialization

Citations

This map shows the geographic impact of Amy C. Doty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy C. Doty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy C. Doty more than expected).

Fields of papers citing papers by Amy C. Doty

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy C. Doty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy C. Doty. The network helps show where Amy C. Doty may publish in the future.

Co-authorship network of co-authors of Amy C. Doty

This figure shows the co-authorship network connecting the top 25 collaborators of Amy C. Doty. A scholar is included among the top collaborators of Amy C. Doty based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy C. Doty. Amy C. Doty is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Yu, Wensheng, Yongqi Deng, David L. Sloman, et al.. (2021). Discovery of IDO1 inhibitors containing a decahydroquinoline, decahydro-1,6-naphthyridine, or octahydro-1H-pyrrolo[3,2-c]pyridine scaffold. Bioorganic & Medicinal Chemistry Letters. 49. 128314–128314. 6 indexed citations

Skomski, Daniel, Zhen Liu, Yongchao Su, et al.. (2020). An Imaging Toolkit for Physical Characterization of Long-Acting Pharmaceutical Implants. Journal of Pharmaceutical Sciences. 109(9). 2798–2811. 10 indexed citations

Chiang, Yuting, Muath Bishawi, C. Wang, et al.. (2020). Successful Gene Delivery to Cardiac Allograft with Adeno-Associated Viral Vector Using Ex Vivo Storage Perfusion Platform. The Journal of Heart and Lung Transplantation. 39(4). S360–S361. 1 indexed citations

Doty, Amy C., Keiji Hirota, Karl Olsen, et al.. (2017). Mechanisms of in vivo release of triamcinolone acetonide from PLGA microspheres. Journal of Controlled Release. 256. 19–25. 77 indexed citations

Doty, Amy C., Keiji Hirota, Karl Olsen, et al.. (2016). Validation of a cage implant system for assessing in vivo performance of long-acting release microspheres. Biomaterials. 109. 88–96. 25 indexed citations

Hirota, Keiji, Amy C. Doty, Rose Ackermann, et al.. (2016). Characterizing release mechanisms of leuprolide acetate-loaded PLGA microspheres for IVIVC development I: In vitro evaluation. Journal of Controlled Release. 244(Pt B). 302–313. 69 indexed citations

Chiang, Bryce, et al.. (2016). Sustained reduction of intraocular pressure by supraciliary delivery of brimonidine-loaded poly(lactic acid) microspheres for the treatment of glaucoma. Journal of Controlled Release. 228. 48–57. 74 indexed citations

Doty, Amy C., Ying Zhang, Stephanie Choi, et al.. (2016). Mechanistic analysis of triamcinolone acetonide release from PLGA microspheres as a function of varying in vitro release conditions. European Journal of Pharmaceutics and Biopharmaceutics. 113. 24–33. 40 indexed citations

Pisal, Dipak S., et al.. (2011). Phosphatidylinositol induces fluid phase formation and packing defects in phosphatidylcholine model membranes. Chemistry and Physics of Lipids. 165(1). 15–22. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact